For US residents only.

How Treatment May Help

TAFINLAR + MEKINIST

TAFINLAR® (dabrafenib) capsules + MEKINIST® (trametinib) tablets was studied in a clinical trial of patients with BRAF+ advanced melanoma. In this trial, TAFINLAR + MEKINIST was proven to help extend patients' lives.*

Watch the video below to learn more about how TAFINLAR + MEKINIST can help patients with BRAF+ advanced melanoma

Clinical Overview

Clinical Overview
14:36

TAFINLAR + MEKINIST may offer a chance to extend your life*

TAFINLAR® (dabrafenib) + MEKINIST® (trametinib) efficacy: OS & PFS TAFINLAR® (dabrafenib) + MEKINIST® (trametinib) efficacy: OS & PFS TAFINLAR® (dabrafenib) + MEKINIST® (trametinib) efficacy: OS & PFS

Overall response rate to TAFINLAR + MEKINIST: More patients had their tumors shrink or disappear than with TAFINLAR alone

TAFINLAR® (dabrafenib) + MEKINIST® (trametinib) efficacy: Response rate TAFINLAR® (dabrafenib) + MEKINIST® (trametinib) efficacy: Response rate TAFINLAR® (dabrafenib) + MEKINIST® (trametinib) efficacy: Response rate